NAS:COEP (USA)
Ordinary Shares
$
9.81
+0.080 (+0.82%)
07:08 PM EST
Warning! GuruFocus detected
1 Severe warning sign
with COEP.
Try a 7-Day Free Trial
to check it out.
What is a stock summary page? Click here for an overview.
Business Description
Coeptis Therapeutics Holdings Inc
NAICS : 541714
SIC : 2836
ISIN : US19207A1088
Share Class Description:
COEP: Ordinary SharesDescription
Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.38 | |||||
| Equity-to-Asset | 0.36 | |||||
| Debt-to-Equity | 0.44 | |||||
| Debt-to-EBITDA | -0.15 | |||||
| Piotroski F-Score | 3/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 26.9 | |||||
| 3-Year EPS without NRI Growth Rate | 28.6 | |||||
| 3-Year FCF Growth Rate | 17.3 | |||||
| 3-Year Book Growth Rate | -13.2 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 62.65 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 60.93 | |||||
| 9-Day RSI | 54.98 | |||||
| 14-Day RSI | 52.34 | |||||
| 3-1 Month Momentum % | -25.5 | |||||
| 6-1 Month Momentum % | 133.04 | |||||
| 12-1 Month Momentum % | 30.52 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.23 | |||||
| Quick Ratio | 0.23 | |||||
| Cash Ratio | 0.12 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -27.5 | |||||
| Shareholder Yield % | -1.38 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -385.13 | |||||
| ROA % | -136.19 | |||||
| ROIC % | -150.45 | |||||
| 3-Year ROIIC % | 119.31 | |||||
| ROC (Joel Greenblatt) % | -11671.49 | |||||
| ROCE % | -305.41 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 6.52 | |||||
| Price-to-Tangible-Book | 7.85 | |||||
| EV-to-EBIT | -3.27 | |||||
| EV-to-Forward-EBIT | -2.93 | |||||
| EV-to-EBITDA | -3.63 | |||||
| EV-to-Forward-EBITDA | -2.93 | |||||
| EV-to-FCF | -5.16 | |||||
| Earnings Yield (Greenblatt) % | -30.58 | |||||
| FCF Yield % | -20.14 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:COEP
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return %
Total Annual Return %
Coeptis Therapeutics Holdings Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -5.121 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | 149.82 | ||
| 14-Day RSI | 52.34 | ||
| 14-Day ATR ($) | 1.01213 | ||
| 20-Day SMA ($) | 9.49725 | ||
| 12-1 Month Momentum % | 30.52 | ||
| 52-Week Range ($) | 2.31 - 13.7 | ||
| Shares Outstanding (Mil) | 3.36 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Coeptis Therapeutics Holdings Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Coeptis Therapeutics Holdings Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Coeptis Therapeutics Holdings Inc Frequently Asked Questions
What is Coeptis Therapeutics Holdings Inc(COEP)'s stock price today?
The current price of COEP is $9.81. The 52 week high of COEP is $13.70 and 52 week low is $2.31.
When is next earnings date of Coeptis Therapeutics Holdings Inc(COEP)?
The next earnings date of Coeptis Therapeutics Holdings Inc(COEP) is 2025-08-15 Est..
Does Coeptis Therapeutics Holdings Inc(COEP) pay dividends? If so, how much?
Coeptis Therapeutics Holdings Inc(COEP) does not pay dividend.
Guru Commentaries on NAS:COEP
No articles.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers